Page last updated: 2024-10-23

bisbenzimidazole and Asymmetric Diabetic Proximal Motor Neuropathy

bisbenzimidazole has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delaney, CL1
Russell, JW1
Cheng, HL1
Feldman, EL1

Other Studies

1 other study available for bisbenzimidazole and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells.
    Journal of neuropathology and experimental neurology, 2001, Volume: 60, Issue:2

    Topics: Animals; Apoptosis; bcl-X Protein; Bisbenzimidazole; Diabetic Neuropathies; Ganglia, Spinal; Glucose

2001